Creatine Treatment Promotes Differentiation of GABA-ergic Neuronal Precursors in Cultured Fetal Rat Spinal Cord
Overview
Authors
Affiliations
Creatine is a substrate of cytosolic and mitochondrial creatine kinases. Its supplementation augments cellular levels of creatine and phosphocreatine, the rate of ATP resynthesis, and improves the function of the creatine kinase energy shuttle. High cytoplasmatic total creatine levels have been reported to be neuroprotective by inhibiting apoptosis. In addition, creatine has direct antioxidant effects, which may be of importance in amyotrophic lateral sclerosis. In the present study, we investigated the effects of creatine [5 mM] on survival and differentiation of cultured GABA-immunoreactive (-ir) and choline acetyltransferase (ChAT)-ir rat spinal cord neurons. Furthermore, we addressed the neuroprotective potential of creatine supplementation against 3-nitropropionic acid (3-NP) induced toxicity. General cell survival and total neuronal cell density were not altered by chronic creatine treatment. We found, however, after chronic creatine and short-term creatine exposure a significantly higher density of GABA-ir neurons hinting to a differentiation-inducing mechanism of creatine. This notion is further supported by a significant higher content of GAD after creatine exposure. Creatine supplementation also exerted a partial, but significant neuroprotection for GABA-ir neurons against 3-NP induced toxicity. Interestingly, chronic creatine treatment did not alter cell density of ChAT-ir neurons but promoted their morphologic differentiation. Cell soma size and number of primary neurites per neuron were increased significantly after creatine supplementation. Taken together, creatine supplementation promoted the differentiation or the survival of GABAergic neurons and resulted in partial neuroprotection against 3-NP induced toxicity. The data suggest that creatine may play a critical role during development of spinal cord neurons.
Shifts in the microbial community and metabolome in rumen ecological niches during antler growth.
Li S, Mu R, Zhu Y, Zhao F, Qiu Q, Si H Comput Struct Biotechnol J. 2024; 23:1608-1618.
PMID: 38680874 PMC: 11047195. DOI: 10.1016/j.csbj.2024.04.018.
Balestrino M, Adriano E, Ali P, Pardini M Brain Sci. 2024; 14(4).
PMID: 38671990 PMC: 11048612. DOI: 10.3390/brainsci14040337.
Creatine Activity as a Neuromodulator in the Central Nervous System.
Meftahi G, Hatef B, Pirzad Jahromi G Arch Razi Inst. 2024; 78(4):1169-1175.
PMID: 38226371 PMC: 10787915. DOI: 10.32592/ARI.2023.78.4.1169.
Sugimoto C, Perna M, Regan S, Tepe E, Liou R, Fritz A Brain Res. 2023; 1825:148690.
PMID: 38030104 PMC: 10875619. DOI: 10.1016/j.brainres.2023.148690.
Duran-Trio L, Fernandes-Pires G, Grosse J, Soro-Arnaiz I, Roux-Petronelli C, Binz P J Inherit Metab Dis. 2021; 45(2):278-291.
PMID: 34936099 PMC: 9302977. DOI: 10.1002/jimd.12470.